Daily Stock Analysis, CRY, CryoLife Inc, priceseries

CryoLife Inc. Daily Stock Analysis
Stock Information
Open
27.48
Close
27.94
High
28.17
Low
27.25
Previous Close
27.33
Daily Price Gain
0.61
YTD High
33.00
YTD High Date
Jul 31, 2019
YTD Low
23.99
YTD Low Date
Feb 14, 2019
YTD Price Change
0.57
YTD Gain
2.08%
52 Week High
36.05
52 Week High Date
Sep 25, 2018
52 Week Low
23.99
52 Week Low Date
Feb 14, 2019
52 Week Price Change
-6.36
52 Week Gain
-18.54%
Recent priceSeries Trade Signals

These are sample algorithmic trades based on actual market data.

Trade Type
Entry Date
Entry Price
Exit Date
Exit Price
Trade Hold Time
Gain
Trade Record
LONG
Apr 20. 2017
15.45
May 17. 2017
18.62
19 Trading Days
20.49%
Link
LONG
Aug 28. 2017
19.25
Sep 19. 2017
22.23
15 Trading Days
15.47%
Link
LONG
Feb 15. 2018
17.90
Mar 20. 2018
20.75
22 Trading Days
15.94%
Link
LONG
Apr 9. 2018
20.35
Apr 27. 2018
22.85
14 Trading Days
12.30%
Link
LONG
Apr 24. 2019
28.94
May 10. 2019
30.75
12 Trading Days
6.26%
Link
Company Information
Stock Symbol
CRY
Exchange
NYSE
Company URL
http://www.cryolife.com
Company Phone
7704193355
CEO
James Patrick Mackin
Headquarters
Georgia
Business Address
1655 ROBERTS BOULEVARD N W, KENNESAW, GA 30144
Sector
Equity
Industry Category
Health Services
Industry Group
Medical Appliances & Equipment
CIK
0000784199
About

CryoLife, Inc. is a medical devices company. It engages in the processing and distribution of implantable human tissues for use in cardiac and vascular surgeries. The company operates in two segments: Medical Devices and Preservation Services. The Medical Devices segment includes external revenues from product sales of BioGlue, BioFoam, PerClot, CardioGenesis cardiac laser therapy, HeRO Graft, and ProCol. The Preservation Services segment offers external services revenues from the preservation of cardiac and vascular tissues. CryoLife was founded by Steven G. Anderson on January 19, 1984 and is headquartered in Kennesaw, GA.

Description

CryoLife, Inc., together with its subsidiaries, manufactures and distributes medical devices worldwide. It also processes and distributes implantable human tissues for use in cardiac and vascular surgeries. The company operates in two segments, Medical Devices and Preservation Services. It offers surgical sealants and hemostats, including BioGlue Surgical Adhesive, an agent for cross-linking proteins for cardiac, vascular, pulmonary, and general surgical applications; BioFoam Surgical Matrix, which is used as an adjunct in sealing abdominal parenchymal tissues, as well as an adjunct for hemostasis in cardiovascular surgery; and PerClot, an absorbable powdered hemostat for use in surgical procedures, including cardiac, vascular, orthopedic, neurological, gynecological, ENT, and trauma surgeries. The company also provides cardiac laser therapy products, which include laser console system and single-use, as well as fiber-optic hand-pieces for the treatment of coronary artery disease in patients with severe angina; and On-X heart valves for aortic and mitral indications. In addition, it distributes ProCol vascular bioprosthesis, a biological graft that provides vascular access for end-stage renal disease in hemodialysis patients; and PhotoFix, a bovine pericardial patch for use in cardiac and vascular repairing activities. Further, it distributes CryoValve SG pulmonary heart valves and CryoPatch SG pulmonary cardiac patch tissues that are processed using its proprietary SynerGraft technology; and vascular preservation services, such as CryoVein and CryoArtery tissues to treat various vascular reconstructions, such as peripheral bypass, hemodialysis access, and aortic infections. The company serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. CryoLife, Inc. was founded in 1984 and is headquartered in Kennesaw, Georgia.